Your browser doesn't support javascript.
loading
Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation.
Fielding, Ceri A; Weekes, Michael P; Nobre, Luis V; Ruckova, Eva; Wilkie, Gavin S; Paulo, Joao A; Chang, Chiwen; Suárez, Nicolás M; Davies, James A; Antrobus, Robin; Stanton, Richard J; Aicheler, Rebecca J; Nichols, Hester; Vojtesek, Borek; Trowsdale, John; Davison, Andrew J; Gygi, Steven P; Tomasec, Peter; Lehner, Paul J; Wilkinson, Gavin W G.
Afiliação
  • Fielding CA; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Weekes MP; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Nobre LV; Department of Cell Biology, Harvard Medical School, Boston, United States.
  • Ruckova E; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Wilkie GS; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Paulo JA; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
  • Chang C; Department of Cell Biology, Harvard Medical School, Boston, United States.
  • Suárez NM; Immunology Division, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Davies JA; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
  • Antrobus R; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Stanton RJ; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
  • Aicheler RJ; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Nichols H; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Vojtesek B; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Trowsdale J; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Davison AJ; Immunology Division, Department of Pathology, University of Cambridge, Cambridge, United Kingdom.
  • Gygi SP; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
  • Tomasec P; Department of Cell Biology, Harvard Medical School, Boston, United States.
  • Lehner PJ; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
  • Wilkinson GW; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, United Kingdom.
Elife ; 62017 02 10.
Article em En | MEDLINE | ID: mdl-28186488
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Virais / Células Matadoras Naturais / Citomegalovirus / Interações Hospedeiro-Patógeno / Fatores Imunológicos / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Virais / Células Matadoras Naturais / Citomegalovirus / Interações Hospedeiro-Patógeno / Fatores Imunológicos / Proteínas de Membrana Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Elife Ano de publicação: 2017 Tipo de documento: Article